Shattuck Labs, Inc. (STTK) Investor Relations Documents

Shattuck Labs, Inc. (STTK) investor relations documents from the company's IR site: 22 presentations, 12 press releases; latest deck 2026-08-11. Read in-app with summaries. First-party data.

Presentation: Shattuck Labs' DR3 blocking antibody SL-325 is entering Phase 2b for Crohn's disease in Q3'26, with $208.3M cash runway to 2029.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-11Press releaseShattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights
2026-08-11PresentationPresentation
2026-08-11Press releasePress Release
2026-06-10Press releaseShattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
2026-06-09Press releaseShattuck Labs, Inc. Announces Proposed Public Offering
2026-06-09Press releaseShattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update
2026-06-08Press releaseShattuck Labs Announces Phase 1 Results for SL-325
2026-06-05Press releaseShattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blo
2026-05-07PresentationPresentation
2026-05-07Press releasePress Release
2026-05-07Press releaseShattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
2026-03-05Press releasePress Release
2026-03-05PresentationPresentation of Q4 2025, PDF file, (opens in new window)
2026-03-05Press releaseDownload (opens in new window)
2026-02-06Press releaseShattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
2025-11-06PresentationPresentation
2025-08-26PresentationPresentation
2025-03-27PresentationPresentation
2025-02-20PresentationEuropean Crohn’s and Colitis Organization (ECCO) Presentation
2025-02-03Presentation2025 Crohn’s and Colitis Congress
2024-11-14PresentationPresentation
2024-10-01PresentationPresentation
2024-05-02PresentationPresentation
2024-02-29PresentationPresentation
2023-11-09PresentationPresentation
2023-08-10PresentationPresentation
2023-02-23PresentationPresentation
2023-01-09PresentationPresentation
2022-08-11PresentationPresentation
2022-07-27Presentation3rd Annual Gamma-Delta T Cell Therapies Summit 2022
2021-12-09PresentationTIGIT Therapies Digital Summit 2021
2021-09-29PresentationMacrophage Directed Therapies Summit 2021
2020-11-01PresentationTaylor Schreiber to Speak at the 2020 CD47/SIRPα Summit
2020-10-01PresentationTaylor Schreiber to Speak at the 2020 TIGIT Therapies Digital Consortium

STTK overview · STTK earnings · STTK financials · STTK KPIs · STTK ownership · STTK peers · STTK filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.